This document summarizes recent advances in asthma and COPD presented between January and December 2016. It describes several studies on new drug combinations that increase lung function and quality of life for COPD patients. It also discusses trials of endobronchial valves and coils that improve outcomes for selected patients with severe emphysema. New biologic drugs targeting specific inflammatory pathways in asthma are presented, along with trials of these new therapies.